P00001606T0076|42 56|5-nucleotidase
P00001606T0076|16 56|alkaline phosphatases and 5-nucleotidase
P00008997A0472|64 65|K
P00008997A0472|5 8|CSF
P00012653T0045|14 20|agents
P00012653T0045|0 13|Beta blocking
P00015731A0090|250 252|pH
P00015731A0090|41 85|carbonic anhydrase inhibitors (acetazolamide
P00023348A0601|68 69|.
P00025557A0100|9 12|CO2
P00025557A0100|29 30|9
P00027967A0207|13 25|secretory HI
P00027967A0207|23 41|HI antibodies were
P00029953T0045|19 34|lipase activity
P00029953T0045|19 35|lipase activity.
P00030937A0119|6 10|SGOT
P00030937A0119|16 51|alkaline phosphatase concentrations
P00034935A0545|26 33|disease
P00034935A0545|24 42|s disease showed a
P00038408T0000|33 52|alpha-autoreceptors
P00038408T0000|99 107|FLA 136.
P00033873T0001|31 35|GGTP
P00033873T0001|31 48|GGTP) activity in
P00030183T0000|37 40|HLA
P00029555A0861|106 110|done
P00029555A0861|103 105|be
P00027739T0000|0 31|Serum gamma glutamyltransferase
P00027739T0000|0 34|Serum gamma glutamyltransferase in
P00024600A0522|13 16|HMG
P00024600A0522|45 50|offer
P00022143T0000|42 45|rat
P00022143T0000|38 45|the rat
P00013683A0210|61 65|VCO2
P00013683A0210|45 48|CO2
P00010943A0733|83 86|use
P00010943A0733|30 32|an
P00008171T0000|0 21|Pharmacologic aspects
P00008171T0000|0 24|Pharmacologic aspects of
P00008171T0000|0 13|Pharmacologic
P00008171T0000|22 24|of
P00010943A0733|27 29|be
P00013683A0210|61 67|VCO2),
P00013683A0210|61 66|VCO2)
P00022143T0000|38 56|the rat and rabbit
P00022143T0000|50 57|rabbit.
P00024600A0522|0 12|The variable
P00024600A0522|0 16|The variable HMG
P00027739T0000|6 34|gamma glutamyltransferase in
P00027739T0000|6 31|gamma glutamyltransferase
P00029555A0861|103 113|be done in
P00029555A0861|103 110|be done
P00030183T0000|41 43|B5
P00030183T0000|37 43|HLA-B5
P00033873T0001|31 36|GGTP)
P00033873T0001|0 29|Gamma glutamyl transpeptidase
P00038408T0000|99 106|FLA 136
P00038408T0000|78 83|alpha
P00034935A0545|24 33|s disease
P00034935A0545|24 25|s
P00030937A0119|16 36|alkaline phosphatase
P00030937A0119|0 4|SGPT
P00029953T0045|26 34|activity
P00029953T0045|19 25|lipase
P00027967A0207|23 36|HI antibodies
P00027967A0207|13 36|secretory HI antibodies
P00025557A0100|67 71|lost
P00023348A0601|25 27|be
P00023348A0601|0 17|Colorectal polyps
P00015731A0090|41 70|carbonic anhydrase inhibitors
P00015731A0090|41 59|carbonic anhydrase
P00012653T0045|0 20|Beta blocking agents
P00012653T0045|0 4|Beta
P00008997A0472|29 30|a
P00001606T0076|16 41|alkaline phosphatases and
P00001606T0076|16 37|alkaline phosphatases
